The Medicines Company Contracts & Agreements

124 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Agreement and Plan of Merger, dated as of November 23, 2019, by and among The Medicines Company, Novartis AG and Medusa Merger Corporation
Merger Agreements
The Medicines Company
Pharmaceuticals
NY
2019
Supplemental Indenture, dated as of January 6, 2020, to the indenture, dated as of January 13, 2015, between the Company and the Trustee
Indenture Agreements
The Medicines Company
2020
Supplemental Indenture, dated as of January 6, 2020, to the indenture, dated as of June 10, 2016, between the Company and the Trustee
Indenture Agreements
The Medicines Company
Pharmaceuticals
DE
2020
Supplemental Indenture, dated as of January 6, 2020, to the indenture, dated as of December 18, 2018, between the Company and the Trustee
Indenture Agreements
The Medicines Company
2020
Underwriting Agreement, dated as of June 25, 2019, by and among the Company, Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC
Underwriting Agreements
The Medicines Company
2019
Separation Agreement, dated March 15, 2019, between Christopher Cox and the registrant
Separation Agreements
The Medicines Company
Pharmaceuticals
NJ
2019
Indenture (including Form of Notes), dated as of December 18, 2018, by and between The Medicines Company and Wells Fargo Bank, National Association, a national banking...
Indenture Agreements
The Medicines Company
Pharmaceuticals
DE
2018
Employment Agreement, dated December 10, 2018, by and between Mark Timney and The Medicines Company
Employment Agreements
The Medicines Company
Pharmaceuticals
DE
2018
Severance Agreement, dated December 10, 2018, by and between Mark Timney and The Medicines Company
Severance Agreements
The Medicines Company
Pharmaceuticals
2018
Form of performance stock option agreement under 2013 Stock Incentive Plan
Bonus & Incentive Agreements
The Medicines Company
Pharmaceuticals
2018
Ninth Amendment to Second Amended and Restated Distribution Agreement, effective October 3, 2017, by and between the registrant and Integrated Commercialization Solutions LLC,...
Distribution Agreements
The Medicines Company
Pharmaceuticals
2018
Amendment, dated November 14, 2017, of the Amended and Restated Employment Agreement between The Medicines Company and Clive Meanwell, dated May 26, 2016
Employment Agreements
The Medicines Company
2018
Purchase and Sale Agreement, dated as of November 28, 2017, by and among The Medicines Company and Melinta Therapeutics, Inc
Purchase Agreements
The Medicines Company
Pharmaceuticals
DE
2017
Amendment No. 2 to the Supply and Distribution Agreement, dated July 1, 2017, by and between registrant and Sandoz Inc
Supply Agreements
The Medicines Company
Pharmaceuticals
DE
2017
Exhibit 10.16 Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Double asterisks denote omissions. SECOND AMENDMENT TO CONTRACT...
Exchange Agreements
The Medicines Company
Pharmaceuticals
2017
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. OTHER TRANSACTION AGREEMENT (OTA) BETWEEN THE...
Exchange Agreements
The Medicines Company
Pharmaceuticals
2016
THE MEDICINES COMPANY AND WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of June 10, 2016 2.75% Convertible Senior Notes due 2023
Indenture Agreements
The Medicines Company
2016
JPMorgan Chase Bank, National Association Organised under the laws of the United States as a National Banking Association. Main Office 1111 Polaris Parkway, Columbus, Ohio 43240...
The Medicines Company
2016
AMENDMENT NO. 3 TO THE MEDICINES COMPANY 2013 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
The Medicines Company
2016
AMENDMENT NO. 1 TO THE MEDICINES COMPANY 2010 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
The Medicines Company
Pharmaceuticals
2016
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
The Medicines Company
Pharmaceuticals
DE
2016
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
The Medicines Company
2016
Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Triple asterisks denote omissions.
The Medicines Company
2016
Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Double asterisks denote omissions.Exhibit 10.21 AMENDMENT TO CONTRACT MANUFACTURING...
Exchange Agreements
The Medicines Company
2016
FIRST AMENDMENT TO CHEMILOG DEVELOPMENT AND SUPPLY AGREEMENT
Development Agreements
The Medicines Company
Pharmaceuticals
2016
Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Double asterisks denote omissions.Exhibit 10.34 SECOND AMENDMENT TO CHEMILOG...
Exchange Agreements
The Medicines Company
Pharmaceuticals
2016
Confidential Materials omitted and filed separately with the
The Medicines Company
2016
INDEMNITY AGREEMENT
The Medicines Company
Pharmaceuticals
DE
2015
SUPPLY AND DISTRIBUTION AGREEMENT
Supply Agreements
The Medicines Company
2015
AMENDMENT NO. 2 TO SUPPLY AGREEMENT By and between Teva API Inc. and The Medicines Company
Supply Agreements
The Medicines Company
Pharmaceuticals
2015
INVESTMENT AGREEMENT
Investment Agreements
The Medicines Company
2015
AMENDMENT NO. 2 TO THE MEDICINES COMPANY 2013 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
The Medicines Company
2015
Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Double asterisks denote omissions. SEVENTH AMENDMENT TO SECOND AMENDED AND RESTATED...
Exchange Agreements
The Medicines Company
2015
Type of FeeAmount of CompensationAnnual retainer for board members$55,000Additional annual retainer for lead director$10,000Compensation for each board meeting attended in excess...
Compensation Agreements
The Medicines Company
2015
Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Double asterisks denote omissions.
The Medicines Company
Pharmaceuticals
DE
2015
SECOND AMENDMENT TO THE CONSULTING AGREEMENT
Consulting Agreements
The Medicines Company
Pharmaceuticals
2015
THIRD AMENDMENT TO THE CONSULTING AGREEMENT
Consulting Agreements
The Medicines Company
Pharmaceuticals
2015
THE MEDICINES COMPANY AND WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of January 13, 2015 2.50% Convertible Senior Notes due 2022
Indenture Agreements
The Medicines Company
Pharmaceuticals
DE
2015
AMENDMENT NO. 1 TO THE MEDICINES COMPANY 2013 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
The Medicines Company
Pharmaceuticals
2014
Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Double asterisks denote omissions.
The Medicines Company
Pharmaceuticals
DE
2014
FIRST AMENDMENT TO GLOBAL COLLABORATION AGREEMENT
Collaboration Agreements
The Medicines Company
Pharmaceuticals
2014
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. SECOND AMENDMENT TO GLOBAL COLLABORATION...
Exchange Agreements
The Medicines Company
2014
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. AGREEMENT AND PLAN OF MERGER by and among THE...
Merger Agreements
The Medicines Company
Pharmaceuticals
DE
2013
Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Double asterisks denote omissions. Dated October 25 2004 (1) Quadrant Drug Delivery...
The Medicines Company
Pharmaceuticals
2013
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. FOURTH AMENDMENT TO SECOND AMENDED AND RESTATED...
Exchange Agreements
The Medicines Company
2013
FIFTH AMENDMENT TO SECOND AMENDED AND RESTATED DISTRIBUTION AGREEMENT
Distribution Agreements
The Medicines Company
2013
THE MEDICINES COMPANY 5,785,123 Shares of Common Stock Underwriting Agreement
Underwriting Agreements
The Medicines Company
2013
THE MEDICINES COMPANY 2013 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
The Medicines Company
Pharmaceuticals
DE
2013
THE MEDICINES COMPANY Non-statutory Stock Option Agreement Granted Under 2013 Stock Incentive Plan
Bonus & Incentive Agreements
The Medicines Company
2013
THE MEDICINES COMPANY Non-statutory Stock Option Agreement Under 2013 Stock Incentive Plan
Bonus & Incentive Agreements
The Medicines Company
2013
THE MEDICINES COMPANY Restricted Stock Agreement Granted Under 2013 Stock Incentive Plan
Bonus & Incentive Agreements
The Medicines Company
Pharmaceuticals
DE
2013
THE MEDICINES COMPANY Restricted Stock Agreement Granted Under 2013 Stock Incentive Plan
Bonus & Incentive Agreements
The Medicines Company
Pharmaceuticals
DE
2013
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. SHARE PURCHASE AGREEMENT BY AND AMONG THE...
Exchange Agreements
The Medicines Company
Pharmaceuticals
DE
2013
Exhibit 10.1Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Asterisks denote omissions.
The Medicines Company
Pharmaceuticals
DE
2013
Exhibit 10.2Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
The Medicines Company
2013
Type of FeeAmount of CompensationAnnual retainer for board members$55,000Additional annual retainer for lead director$10,000Attendance for each board meeting attended in...
Compensation Agreements
The Medicines Company
Pharmaceuticals
2013
AMENDMENT TO THE CONSULTING AGREEMENT
Consulting Agreements
The Medicines Company
2013
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. AGREEMENT AND PLAN OF MERGER by and among THE...
Merger Agreements
The Medicines Company
Pharmaceuticals
DE
2013
Exhibit 10.1Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Asterisks denote omissions.
The Medicines Company
Pharmaceuticals
2012
Exhibit 10.2 CONSULTING AGREEMENT
Consulting Agreements
The Medicines Company
Pharmaceuticals
NJ
2012
Exhibit 10.1Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Asterisks denote omissions. SEVERANCE AGREEMENT AND FULL AND FINAL...
Exchange Agreements
The Medicines Company
2012
Exhibit 10.2Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Asterisks denote omissions.
The Medicines Company
2012
Exhibit 10.3Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Asterisks denote omissions. THIRD AMENDMENT TO SECOND AMENDED AND...
Exchange Agreements
The Medicines Company
Pharmaceuticals
2012
THE MEDICINES COMPANY AND WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of June 11, 2012 1.375% Convertible Senior Notes due 2017
Indenture Agreements
The Medicines Company
2012
Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Asterisks denote omissions. Exhibit 10.1
The Medicines Company
2012
Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Asterisks denote omissions. Exhibit 10.2 LICENSE AGREEMENT BY AND AMONG THE...
Exchange Agreements
The Medicines Company
2012
Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Asterisks denote omissions. Exhibit 10.3
The Medicines Company
2012
Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Asterisks denote omissions. Exhibit 10.4
The Medicines Company
Pharmaceuticals
DE
2012
Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Asterisks denote omissions. Exhibit 10.5
The Medicines Company
Pharmaceuticals
DE
2012
Confidential Materials omitted and filed separately with theSecurities and Exchange Commission. Asterisks denote omissions. Exhibit 10.6 AMENDMENT NO. 1 TO SUPPLY AGREEMENT By and...
Exchange Agreements
The Medicines Company
2012
Confidential Materials omitted and filed separately with the Securities and Exchange Commissions. Asterisks denote omissions. Manufacturing Services Agreement March 30, 2011
Exchange Agreements
The Medicines Company
2011
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. SETTLEMENT AGREEMENT BY AND AMONG THE MEDICINES...
Exchange Agreements
The Medicines Company
Pharmaceuticals
2011
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. LICENSE AGREEMENT BY AND AMONG THE MEDICINES COMPANY...
Exchange Agreements
The Medicines Company
Pharmaceuticals
NY
2011
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. SUPPLY AGREEMENT (the "Agreement") entered into on...
Supply Agreements
The Medicines Company
2011
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. FIRST AMENDMENT TO SECOND AMENDED AND RESTATED...
Exchange Agreements
The Medicines Company
2011
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. SECOND AMENDMENT TO SECOND AMENDED AND RESTATED...
Exchange Agreements
The Medicines Company
2011
FOURTH AMENDMENT TO LEASE
Lease Agreements
The Medicines Company
Pharmaceuticals
2011
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions SETTLEMENT AGREEMENT AND RELEASE
Exchange Agreements
The Medicines Company
2011
EX-101 INSTANCE DOCUMENT
The Medicines Company
Pharmaceuticals
MA
2011
EX-101 INSTANCE DOCUMENT
The Medicines Company
Pharmaceuticals
2011
EX-101 INSTANCE DOCUMENT
The Medicines Company
2011
EX-101 INSTANCE DOCUMENT
The Medicines Company
Pharmaceuticals
NY
2011
EX-101 INSTANCE DOCUMENT
The Medicines Company
2010
EX-101 INSTANCE DOCUMENT
The Medicines Company
2010
Current assets
The Medicines Company
2010
Product or Product
The Medicines Company
2010
Product or Product
The Medicines Company
2010
Product or Product
The Medicines Company
Pharmaceuticals
NY
2010
Current assets
The Medicines Company
Pharmaceuticals
NJ
2009
Current assets
The Medicines Company
2009
Current assets
The Medicines Company
Pharmaceuticals
2009
Current assets
The Medicines Company
2009
Current assets
The Medicines Company
2009
Current assets
The Medicines Company
Pharmaceuticals
2009
Current assets
The Medicines Company
2009
Current assets
The Medicines Company
2009
Current assets
The Medicines Company
Pharmaceuticals
DE
2009
EX-10.18: LEASE
Lease Agreements
The Medicines Company
2009
EX-10.24: FORM OF AMENDED AND RESTATED MANAGEMENT SEVERANCE AGREEMENT
Severance Agreements
The Medicines Company
Pharmaceuticals
2009
EX-10.25: FORM OF AMENDED AND RESTATED MANAGEMENT SEVERANCE AGREEMENT
Severance Agreements
The Medicines Company
2009
EX-10.38: AMENDMENT NO.2 TO LICENSE AGREEMENT
License Agreements
The Medicines Company
Pharmaceuticals
2009
EX-10.40: AMENDMENT TO LEASE
Lease Agreements
The Medicines Company
2009
EX-10.42: SEVERANCE AGREEMENT
Severance Agreements
The Medicines Company
2009
AGREEMENT AND PLAN OF MERGER by and among The Medicines Company, Boxford Subsidiary Corporation and Targanta Therapeutics Corporation Dated as of January 12, 2009
Merger Agreements
The Medicines Company
Pharmaceuticals
DE
2009
Confidential Materials omittedand filed separately with the Securities and ExchangeCommission. Asterisks denote omissions. PUBLIC DEED WILMERHALE Sale and Purchase Agreement...
Exchange Agreements
The Medicines Company
2008
Summary of Annual Cash Bonus Plan
Bonus & Incentive Agreements
The Medicines Company
2008
Summary of The Medicines Company Board of Directors Compensation
Compensation Agreements
The Medicines Company
2007
CONSULTING AGREEMENT
Consulting Agreements
The Medicines Company
2007
ConfidentialMaterials omitted and filed separately with the Securities and Exchange Commission.Asterisks denote omissions. AMENDMENT NO. 1 TO LICENSE AGREEMENT
Exchange Agreements
The Medicines Company
2006
THE MEDICINES COMPANY 2004 STOCK INCENTIVE PLAN(1)
Bonus & Incentive Agreements
The Medicines Company
2006
THE MEDICINES COMPANY 2000 EMPLOYEE STOCK PURCHASE PLAN1
Stock Agreements
The Medicines Company
2006
THE MEDICINESCOMPANY Restricted Stock Agreement Granted Under 2004 Stock Incentive Plan
Bonus & Incentive Agreements
The Medicines Company
2006
The Medicines Company 8 Campus Drive Parsippany, New Jersey 07054 December 23, 2005
The Medicines Company
2006
THIRD AMENDMENT TO LEASE
Lease Agreements
The Medicines Company
2005
THE MEDICINES COMPANY Nonstatutory Stock Option Agreement Under 2004 Stock Incentive Plan
Bonus & Incentive Agreements
The Medicines Company
2005
APPENDIX 1 DEFINED TERMS
The Medicines Company
2005
CONSULTING AGREEMENT
Consulting Agreements
The Medicines Company
2005
Summary ofThe Medicines Company Board of Director Compensation
Compensation Agreements
The Medicines Company
2005
Development and SupplyAgreement
Development Agreements
The Medicines Company
2004
FIRST AMENDMENT TO EMPLOYMENT AGREEMENT
Employment Agreements
The Medicines Company
2004
THE MEDICINES COMPANY 2004 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
The Medicines Company
2004
THE MEDICINES COMPANY Nonstatutory StockOption Agreement Under 2004 Stock Incentive Plan
Bonus & Incentive Agreements
The Medicines Company
2004
THE MEDICINES COMPANY Nonstatutory StockOption Agreement Under 1998 Stock Incentive Plan
Bonus & Incentive Agreements
The Medicines Company
2004
Tenth Amendment to Second Amended and Restated Distribution Agreement, effective April 30, 2018, by and between the registrant and Integrated Commercialization Solutions LLC,...
Distribution Agreements
The Medicines Company
Pharmaceuticals
2018